Qiagen To Market HLA Typing Technology from Genome Diagnostics | GenomeWeb
NEW YORK (GenomeWeb News) – Qiagen secured commercial rights to sell reagents and software for Genome Diagnostics' sequencing based typing technology, Genome Diagnostics said yesterday.
The Dutch company has developed a proprietary strategy for typing human leukocyte antigen genes. Qiagen will have global distribution rights to the technology as of January 2007.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.